Conjunctivitis, commonly known as pink eye, is an inflammation of the conjunctiva, the thin and transparent membrane covering the white part of the eye and the inner surface of the eyelids. This condition can be caused by viruses, bacteria, allergens, or irritants, leading to redness, itching, tearing, and discharge from the eyes. Viral conjunctivitis is often associated with respiratory infections, while bacterial conjunctivitis can result from various bacteria strains. Allergic conjunctivitis is triggered by allergens like pollen or pet dander, and irritant conjunctivitis can occur due to exposure to smoke or chemicals. Diagnosis involves a thorough eye examination, and treatment depends on the underlying cause. Viral conjunctivitis is typically self-limiting, while bacterial conjunctivitis may require antibiotic eye drops or ointments. Allergic conjunctivitis may be managed with antihistamines or other allergy medications. Preventive measures include practicing good hand hygiene, avoiding touching the eyes, and managing allergies. Conjunctivitis is highly contagious, and individuals with symptoms should take precautions to prevent its spread. Timely diagnosis and appropriate management help alleviate symptoms and reduce the risk of complications.
Khursheed Anwer
IMUNON, United States
Ping Xie
Rutgers University, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Lara Isis Teodoro
Mayo Clinic, United States
Ahmed Abdulazeez
BHRUT Trust, United Kingdom
Elena Chiappini
University of Florence, Italy
Ayesha Zahid
Griffith University, Australia
Livia Daflon Silva
Federal University of State of Rio de Janeiro, Brazil
Neha Bhandari
Chitkara University, IndiaSubmit your abstract Today
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States